Novaestiq Corp. — Form D/A
Novaestiq Corp. of SOUTHLAKE, TX, a company, filed a Form D amendment with the SEC on 2023-12-20. The offering totals $7.5M, of which $3.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-12-20
- Form: D/A
- Accession: 0001877943-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $3.8M
- Remaining: $3.7M
- Investors: 23
- Date of first sale: 2021-07-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-410241
Issuer
- Name: Novaestiq Corp.
- CIK: 0001877943
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1560 EAST SOUTHLAKE BOULEVARD, SOUTHLAKE, TX, 76092
- Phone: 817-781-0142
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Miles David Harrison | Director | Southlake, TX |
| Miles David Harrison | Executive Officer | Southlake, TX |
| Humberto David Antunes | Director | Southlake, TX |
| Humberto David Antunes | Executive Officer | Southlake, TX |
| Ethan David Rigel | Executive Officer | Southlake, TX |
| Andreas David Prinz | Director | Southlake, TX |
Other filings by this issuer (4)
More